Results 201 to 210 of about 450,538 (349)

SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI

open access: yesESC Heart Failure, EarlyView.
Abstract In the 2021 European Society of Cardiology (ESC) heart failure (HF) guidelines, sodium–glucose cotransporter 2 (SGLT2) inhibitors were recommended for the prevention of HF in patients with type 2 diabetes mellitus (T2DM) and for the treatment of HF with reduced ejection fraction (HFrEF).
Marco Metra   +25 more
wiley   +1 more source

Incidence and Recurrence of Urinary Tract Infections Caused by Uropathogenic Escherichia coli: A Retrospective Cohort Study

open access: yesResearch and Reports in Urology
Eva Raphael,1,2 Lorenzo Argante,3 Elisa Cinconze,3 Sara Nannizzi,3 Cheyenne Belmont,1 Claire F Mastrangelo,4 Yuan Hu Allegretti,5 Michele Pellegrini,3 Johannes E Schmidt3 1Department of Epidemiology and Biostatistics, University of California, San ...
Raphael E   +8 more
doaj  

Antimicrobial treatment ameliorates delirium-like phenotypes in a murine model of urinary tract infection. [PDF]

open access: yesTransl Psychiatry
Winzey KD   +10 more
europepmc   +1 more source

Three-day and ten-day chemotherapy for urinary tract infections in general practice. [PDF]

open access: bronze, 1976
Clive Charlton   +6 more
openalex   +1 more source

Medication adherence in patients with acutely decompensated heart failure: A cross‐sectional study in the emergency department (ADHF‐ED)

open access: yesEuropean Journal of Heart Failure, EarlyView.
The ADHF‐ED trial. ADHF, acutely decompensated heart failure; CHF, chronic heart failure; ED, emergency department; EF, ejection fraction; MRA, mineralocorticoid receptor antagonist; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Created with the support of AI (ChatGPT).
Michael Kunz   +9 more
wiley   +1 more source

Urinary tract infection in young women, with special reference to Staphylococcus saprophyticus. [PDF]

open access: bronze, 1978
W. A. Gillespie   +5 more
openalex   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

open access: yesEnvironmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy